Why the study?
Does pterostilbene complexed with HPβCD improve right ventricular function and reduce oxidative stress in a rat model of monocrotaline-induced pulmonary hypertension?
Does pterostilbene complexed with HPβCD improve right ventricular function and reduce oxidative stress in a rat model of monocrotaline-induced pulmonary hypertension?
Pterostilbene complexed with HPβCD prevents maladaptive remodeling and preserves right ventricular systolic function in a rat model of pulmonary hypertension.
Suggests a potential therapeutic pathway for preserving right ventricular function in pulmonary hypertension; leaves open.
BACKGROUND AND PURPOSE: In cor pulmonale, the increased afterload imposed on the right ventricle (RV) generates a maladaptive response, impairing the contractile cardiac function. Oxidative mechanisms play an important role in the pathophysiology and progression of this disease. The administration of pterostilbene (PTS), a phytophenol with antioxidant potential, may represent a therapeutic option. In the present study, we evaluated the effect of PTS complexed with hydroxypropyl-β-cyclodextrin (HPβCD) on hypertrophy, contractile function and oxidative parameters in the RV of rats with pulmonary hypertension, induced by the administration of monocrotaline (MCT). EXPERIMENTAL APPROACH: , p.o., for 14 days. The diastolic function, E/A ratio, and systolic function, shortening fraction, fractional area change (FAC) and tricuspid annular plane systolic excursion (TAPSE) of the RV were determined by echocardiography. KEY RESULTS: The PTS : HPβCD complex reduced the production of NADPH oxidase-dependent superoxide anions and oxidative stress in the RV of MCT-treated rats in a dose-dependent manner. At higher doses it prevented the reduction in FAC and TAPSE in MCT-treated animals. CONCLUSIONS AND IMPLICATIONS: The PTS : HPβCD complex prevented the maladaptative remodelling and protected systolic function in the RV of rats with pulmonary hypertension. These cardioprotective mechanisms may be related, in part, to the antioxidant potential of PTS, favoured by the increased p.o. bioavailability promoted by the presence of HPβCD in the complex.
No takes yet. Share an insight, caveat, or question.
Lacerda et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: